Integrated Filing-Governance



General information about company

Scrip Code 532843
NSE Symbol FORTIS
MSEI Symbol NOTLISTED
ISIN INE061F01013
Name of the entity Fortis Healthcare Limited
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Reporting Quarter Yearly
Date of Quarter Ending 31-Mar-2026
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? No
Reason For Part C Of Annexure I Disclosure Of Acquisition Of Shares OrVotingRightsInUnlistedCompaniesIsNotApplicableToTheEntity There was no acquisition of shares or voting rights in Unlisted Companies during the Quarter and year ended March 31, 2026. However, the company through its wholly owned subsidiary i.e. International Hospital Limited (IHL) had executed definitive agreements on December 19, 2025, at 11:25 PM (IST) for the acquisition of 100% stake of TMI Healthcare Private Limited through a Share Purchase Agreement. The said transaction was disclosed to the stock exchanges on December 20, 2025. The acquisition was subsequently consummated and was reported to the stock exchange on January 9, 2026
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? Yes
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? Yes
Whether Annexure I (Part F) of the SEBI Circular dated December 31, 2024 related to Disclosure Of Loans / Guarantees / Comfort Letters / Securities Etc. is Applicable to the entity? Yes
Risk management committee Yes
Market Capitalisation as per immediate previous Financial Year Top 500 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID f00057
Reason For No SCORE ID
Type of Submission New
Remarks (website dissemination)



Annexure I
Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO No Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. Leo Puri 01764813 Non-Executive - Independent Director Chairperson 03-Jan-1961 No Active NA 27-Dec-2024 16 2 2 1 1
2 Mr. Indrajit Banerjee 01365405 Non-Executive - Independent Director Not Applicable 14-Jan-1956 No Active NA 27-Apr-2018 27-Apr-2023 95 2 2 5 3
3 Mr. Ashutosh Raghuvanshi 02775637 Executive Director Not Applicable CEO-MD 11-Aug-1962 No Active NA 19-Mar-2019 19-Mar-2025 1 0 1 0
4 Ms. Suvalaxmi Chakraborty 00106054 Non-Executive - Independent Director Not Applicable 22-Jul-1966 No Active NA 27-Apr-2018 27-Apr-2023 95 2 2 4 3
5 Mr. Dilip Kadambi 02148022 Non-Executive - Non Independent Director Not Applicable 02-Aug-1974 No Active NA 04-Jun-2020 1 0 0 0
6 Mr. Ashok Pandit 09279899 Non-Executive - Non Independent Director Not Applicable 24-Dec-1965 No Active NA 13-Sep-2023 1 0 3 0
7 Mr. Prem Kumar Nair 10348774 Non-Executive - Non Independent Director Not Applicable 25-Aug-1960 No Active NA 10-Nov-2023 1 0 0 0 Textual Information(1)
8 Mr. Keith Hsiu Chin Lim 11276851 Non-Executive - Non Independent Director Not Applicable 21-May-1974 No Active NA 09-Sep-2025 1 0 0 0 Textual Information(2)
9 Mr. Mohd Shahazwan Bin Mohd Harris 08465456 Non-Executive - Non Independent Director Not Applicable 24-Dec-1971 No Active NA 19-Dec-2025 1 0 0 0 Textual Information(3)



Text Block
Textual Information(1) Foreign Director
Textual Information(2) Foreign Director
Textual Information(3) Foreign Director



Annexure 1

II. Composition of Committees
Disclosure of notes on composition of committees explanatory



Audit Committee Details
Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 01365405 Indrajit Banerjee Non-Executive - Independent Director Chairperson 13-Nov-2018
2 09279899 Ashok Pandit Non-Executive - Non Independent Director Member 30-Oct-2023
3 00106054 Suvalaxmi Chakraborty Non-Executive - Independent Director Member 13-Nov-2018



Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00106054 Suvalaxmi Chakraborty Non-Executive - Independent Director Chairperson 27-Jun-2025
2 01365405 Indrajit Banerjee Non-Executive - Independent Director Member 13-Nov-2018
3 10348774 Prem Kumar Nair Non-Executive - Non Independent Director Member 10-Nov-2023



Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 01365405 Indrajit Banerjee Non-Executive - Independent Director Chairperson 13-Nov-2018
2 02775637 Ashutosh Raghuvanshi Executive Director Member 27-Jul-2021
3 09279899 Ashok Pandit Non-Executive - Non Independent Director Member 27-Jun-2025



Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 01764813 Leo Puri ID Chairperson 27-Jun-2025
2 02775637 Ashutosh Raghuvanshi ED Member 15-Oct-2020
3 02148022 Dilip Kadambi NED Member 29-Sep-2023
4 03551067 Bishnu Prasad Panigrahi Head Group Medical Strategy and Operations Member 15-Oct-2020 Textual Information(1)
5 02407380 Anil Vinayak Group Chief Operating Officer Member 15-Oct-2020 Textual Information(2)



Text Block
Textual Information(1) Pursuant to the provisions of Regulation 21 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable laws, Risk Management Committee of the Company is constituted with following members: 1. Mr. Dilip Kadambi, Non-Executive Director, Member 2. Dr. Ashutosh Raghuvanshi, MD & CEO, Member 3. Mr. Anil Vinayak, Group Chief Operating Officer, Member 4. Dr. Bishnu Panigrahi, Head - Group Medical Strategy and Operations, Member 5. Leo Puri, Non-Executive Independent Director, Chairperson
Textual Information(2) Pursuant to the provisions of Regulation 21 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable laws, Risk Management Committee of the Company is constituted with following members: 1. Mr. Dilip Kadambi, Non-Executive Director, Member 2. Dr. Ashutosh Raghuvanshi, MD & CEO, Member 3. Mr. Anil Vinayak, Group Chief Operating Officer, Member 4. Dr. Bishnu Panigrahi, Head - Group Medical Strategy and Operations, Member 5. Leo Puri, Non-Executive Independent Director, Chairperson



Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 01-Oct-2025 Yes 9 6 2
2 11-Nov-2025 40 Yes 9 9 3
3 26-Nov-2025 14 Yes 9 9 3
4 13-Feb-2026 78 Yes 9 6 3
5 19-Mar-2026 33 Yes 9 9 3



Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 04-Nov-2025 Yes 3 3 2 0
2 Audit Committee 11-Nov-2025 6 Yes 3 3 2 0
3 Audit Committee 13-Feb-2026 93 Yes 3 3 2 0
4 Audit Committee 18-Mar-2026 32 Yes 3 3 2 0
5 Audit Committee 23-Mar-2026 4 Yes 3 3 2 0
6 Stakeholders Relationship Committee 11-Nov-2025 Yes 3 3 1 0
7 Stakeholders Relationship Committee 13-Feb-2026 93 Yes 3 2 1 0
8 Nomination and remuneration committee 11-Nov-2025 Yes 3 3 2 0
9 Nomination and remuneration committee 11-Feb-2026 91 Yes 3 3 2 0
10 Risk Management Committee 15-Oct-2025 Yes 3 3 1 2
11 Risk Management Committee 23-Mar-2026 158 Yes 3 3 1 2



Annexure 1
VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here:



Annexure 1
Sr Subject Compliance status
1 Name of signatory Mr. Satyendra Chauhan
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of LODR Regulation
Sr Item Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here. Web address
1.1 Details of business Yes https://www.fortishealthcare.com/about-us
1.2 Memorandum of Association and Articles of Association Yes https://www.fortishealthcare.com/investor/agm%202024/moa%20&%20aoa_fortis%20healthcare%20limited
1.3 Brief profile of board of directors including directorship and full time positions in body corporates Yes https://www.fortishealthcare.com/investors
2 Terms and conditions of appointment of independent directors Yes https://www.fortishealthcare.com/investor/policies%20&%20code/terms%20and%20conditions%20of%20appointment%20of%20independent%20directors
3 Composition of various committees of board of directors Yes https://www.fortishealthcare.com/investors/composition-of-committees/485
4 Code of conduct of board of directors and senior management personnel Yes https://www.fortishealthcare.com/investor/policies%20&%20code/code%20of%20conduct
5 Details of establishment of vigil mechanism or whistle blower policy Yes https://www.fortishealthcare.com/investor/policies%20&%20code/whistle%20blower%20policy
6 Criteria of making payments to non-executive directors Yes https://www.fortishealthcare.com/investor/annual%20reports/fhl%20annual%20report%202024-25
7 Policy on dealing with related party transactions Yes https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20related%20party%20transactions
8 Policy for determining material subsidiaries Yes https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20material%20subsidiary
9 Details of familiarization programmes imparted to independent directors Yes https://www.fortishealthcare.com/investor/familiarization%20programmes/familarization%20program%202024-25
10 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances Yes https://www.fortishealthcare.com/investors
11 Email address for grievance redressal and other relevant details Yes https://www.fortishealthcare.com/investor/grievance%20redressal/grievance%20redressal
12 Financial results Yes https://www.fortishealthcare.com/investors/outcome-of-board-meeting/516
13 Shareholding pattern Yes https://www.fortishealthcare.com/investors/shareholding-pattern/498
14 Details of agreements entered into with the media companies and/or their associates NA
15.1 Schedule of analyst or institutional investor meet and presentation prepared by listed entity for analyst or institutional investor meet Yes https://www.fortishealthcare.com/investors/conference-call-invite/496
15.2 Audio or video recordings and transcripts of post earnings/quarterly calls Yes https://www.fortishealthcare.com/investors/investor-presentations-&-transcripts/494
16 New name and the old name of the listed entity NA
17 Advertisements as per regulation 47 (1) Yes https://www.fortishealthcare.com/investors/newspaper-publications/521
18 Credit rating or revision in credit rating obtained Yes https://www.fortishealthcare.com/investors/credit-ratings/519
19 Separate audited financial statements of each subsidiary of the listed entity Yes https://www.fortishealthcare.com/investors/financials-of-subsidiaries/478
20 Secretarial compliance report Yes https://www.fortishealthcare.com/investors/annual-secretarial-compliance-report/482
21 Materiality policy as per regulation 30 (4) Yes https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20determination%20of%20materiality%20of%20events%20&%20information
22 Disclosure of contact details of KMP who are authorized for the purpose of determining materiality as required under regulation 30(5) Yes https://www.fortishealthcare.com/investors
23 Disclosures under regulation 30(8) Yes https://www.fortishealthcare.com/investors/disclosure-under-reg.-30-of-sebi-(lodr)/513
24 Statements of deviation(s) or variations(s) as specified in regulation 32 NA
25 Dividend distribution policy as specified in regulation 43A (1) Yes https://www.fortishealthcare.com/investor/policies%20&%20code/dividend%20distribution%20policy
26.1 Annual return as provided under section 92 of the Companies Act 2013 Yes https://www.fortishealthcare.com/investors/annual-return/479
26.2 Employee benefit scheme documents framed in terms of SEBI (SBEB) regulations 2021
27 Confirmation that the above disclosures are in a separate section as specified in regulation 46(2) Yes https://www.fortishealthcare.com/investors
28 Compliance with regulation 46(3) with respect to accuracy of disclosures on the website and timely updation Yes https://www.fortishealthcare.com/investors
29 Disclosure of notes on website in terms of Listing Regulations explanatory


Annexure II
II. Annual Affirmations
Sr Particulars Regulation Number Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here.
1 Independent director(s) have been appointed in terms of specified criteria of independence and/or eligibility 16(1)(b) Yes
2 Board Composition 17(1), 17(1A) & 17(1C), 17(1D) & 17(1E) Yes
3 Meeting Of Board Of Directors 17(2) Yes
4 Quorum of board meeting 17(2A) Yes
5 Review of Compliance Reports 17(3) Yes
6 Plans for orderly succession for appointments 17(4) Yes
7 Code of Conduct 17(5) Yes
8 Fees/compensation 17(6) Yes
9 Minimum Information 17(7) Yes
10 Compliance Certificate 17(8) Yes
11 Risk Assessment & Management 17(9) Yes
12 Performance Evaluation of Independent Directors 17(10) Yes
13 Recommendation of Board 17(11) Yes
14 Maximum number of Directorships 17A Yes
15 Composition of Audit Committee 18(1) Yes
16 Meeting of Audit Committee 18(2) Yes
17 Role of Audit Committee and information to be reviewed by the audit committee 18(3) Yes
18 Composition of nomination & remuneration committee 19(1) & (2) Yes
19 Quorum of Nomination and Remuneration Committee meeting 19(2A) Yes
20 Meeting of Nomination and Remuneration Committee 19(3A) Yes
21 Role of Nomination and Remuneration Committee 19(4) Yes
22 Composition of Stakeholder Relationship Committee 20(1), 20(2) & 20(2A) Yes
23 Meeting of Stakeholders Relationship Committee 20(3A) Yes
24 Role of Stakeholders Relationship Committee 20(4) Yes
25 Composition and role of risk management committee 21(1),(2),(3),(4) Yes
26 Meeting of Risk Management Committee 21(3A) Yes
27 Quorum of Risk Management Committee meeting 21(3B) Yes
28 Gap between the meetings of the Risk Management Committee 21(3C) NA
29 Vigil Mechanism 22 Yes
30 Policy for related party Transaction 23(1), (1A), (5), (6), & (8) Yes
31 Prior or Omnibus approval of Audit Committee for all related party transactions 23(2), (3) Yes
32 Approval for material related party transactions 23(4) Yes
33 Disclosure of related party transactions on consolidated basis 23(9) Yes
34 Composition of Board of Directors of unlisted material Subsidiary 24(1) Yes
35 Other Corporate Governance requirements with respect to subsidiary of listed entity 24(2),(3),(4),(5) & (6) Yes
36 Alternate Director to Independent Director 25(1) NA
37 Maximum Tenure 25(2) Yes
38 Appointment, Re-appointment or removal of an Independent Director through special resolution or the alternate mechanism 25(2A) Yes
39 Meeting of independent directors 25(3) & (4) Yes
40 Familiarization of independent directors 25(7) Yes
41 Declaration from Independent Director 25(8) & (9) Yes
42 Directors and Officers insurance 25(10) Yes
43 Confirmation with respect to appointment of Independent Directors who resigned from the listed entity 25(11) Yes
44 Memberships in Committees 26(1) Yes
45 Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel 26(3) Yes
46 Policy with respect to Obligations of directors and senior management 26(2) & 26(5) Yes
47 Approval of the Board and shareholders for compensation or profit sharing in connection with dealings in the securities of the listed entity 26(6) Yes
48 Vacancies in respect Key Managerial Personnel 26A(1) & 26A(2), 26A(3) Yes
Any other information to be provided - Add Notes



Annexure II
III. Affirmations
Sr Particulars Compliance status (Yes/No/NA)
1 The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied Yes
Any other information to be provided



Annexure II
1 Name of signatory Mr. Satyendra Chauhan
2 Designation Company Secretary and Compliance Officer



Additional Half yearly Disclosure
Any Other Information for Disclosure of Loans / Guarantees / Comfort Letters / Securities Etc.
I. Disclosure of Loans/ guarantees/comfort letters /securities etc.refer note below
(A)Any loan or any other form of debt advanced by the listed entity directly or indirectly to
Entity Aggregate amount advanced during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them 0 6376599999
Promoter Group or any other entity controlled by them 0 0
Directors (including relatives) or any other entity controlled by them 0 0
KMPs or any other entity controlled by them 0 0
(B) Any guarantee / comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed By
Entity Type (guarantee, comfort letter etc.) Aggregate amount of issuance during six months Balance outstanding at the end of six months(taking into account any invocation)
Promoter or any other entity controlled by them 0 0 0
Promoter Group or any other entity controlled by them 0 0 0
Directors (including relatives) or any other entity controlled by them 0 0 0
KMPs or any other entity controlled by them 0 0 0
(C) Any security provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by
Entity Type of security (cash, shares etc.) Aggregate value of security provided during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them 0 0 0
Promoter Group or any other entity controlled by them 0 0 0
Directors (including relatives) or any other entity controlled by them 0 0 0
KMPs or any other entity controlled by them 0 0 0
(D) Additional Information Textual Information(1)
II. Affirmations
Affirmations Compliance Status Company Remarks
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company. Yes
Name Vivek Kumar Goyal
Designation Chief Financial Officer
Place Gurugram
Date 28-Apr-2026



Text Block
Textual Information(1) The amount of Rs. 6376599999/- includes : (A) Intercorporate deposits given to entities related to erstwhile promoters- Rs. 44,503 lacs. (Including Interest accrued up to March 31, 2018) (B) Intercorporate deposits given for settlement of outstanding loans of certain parties including erstwhile promoters towards part funding of a property in Birdie & Birdie Realtors Private Limited, (FHL Group Company) the valuation of which is under investigation- Rs. 12,275 lacs. Consequent to NCLT Orders received during the current year ended March 31, 2026, Birdie & Birdie Realtors Private Limited has been merged with Fortis Hospitals Limited (FHL Group Company). Accordingly, aforesaid amount of Rs. 12,275 lacs has been eliminated in the books of account being Intercorporate deposits. (C) Inter corporate deposits to subsidiaries for repayment of outstanding loans of entities related to erstwhile promoter- Rs. 1,010 lacs. Out of it, consequent to NCLT Orders received during the current year ended March 31, 2026, Fortis Emergency Services Limited (FHL Group Company) has been merged with Fortis Hospitals Limited. Accordingly, an amount of Rs. 215 lacs has been eliminated in the books of account being Intercorporate deposits.



Signatory Details
Name of signatory Mr. Satyendra Chauhan
Designation of person Company Secretary and Compliance Officer
Place Gurugram
Date 28-Apr-2026


Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter 0
No. of investor complaints received during the Quarter 0
No. of investor complaints disposed off during the Quarter 0
No. of investor complaints those remaining unresolved at the end of the Quarter 0


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below
Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:
Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible
1 Income Tax Penalty u/s 270A of Rs.5,99,217 on account of disallowance of expense in assessment order for assessment year 2017-18 25-Mar-2026 Penalty is pursuant to disallowance of expense as made by A.O. in assessment order for assessment year 2017-18. 599217


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute
1 Income Tax Department 09-Aug-2021 On appeal by the Company (Fortis Hospitals Limited) for Assessment Year 2017-18, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order on 29.01.2021 with no adverse inference. Later on, Assessing Officer (AO) has passed assessment order dt. 09.08.2021 making disallowances: -Rs.3,26,81,835 u/s 14A -Rs.28,96,72,142 - unexplained cash credit u/s 68 computed as per section 115BBE @ 60%. Amount under litigation is Rs. 26,56,61,808 and the matter is currently pending before Commissioner of Income Tax (Appeals). No Change
2 Income Tax Department 29-Sep-2021 On appeal by the Company (Fortis Hospitals Limited) for Assessment Year 2019-20, Assessment was completed vide order dated 29.09.2021 making disallowances on account of: -14A r.w Rule 8D at Rs.5,37,26,805/- -Disallowance of bad debts at Rs.25,49,02,000/- -Advances from customers/patients at Rs.42,65,12,000/- -Disallowance of ICDs based on SEBI ordes at Rs.402,43,62,000/- Assessing income at Rs.108,58,49,650/- as against loss at Rs.367,36,53,160/- Amount under litigation is Rs. 44,04,72,119 and the matter is currently pending before Commissioner of Income Tax (Appeals). No change
3 Income Tax Department 11-Feb-2019 On appeal by the Company (Fortis Hospotel Limited) for Assessment Year 2015-16, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order proposing adjustment. Later on, Assessing Officer (AO) has passed assessment order confirming the adjustment proposed in TP Order, being interest amount paid on Compulsorily Convertible Debentures (CCDs) issued by the company. Amount under litigation is Rs. 71,18,64,960 and the matter is currently pending before Commissioner of Income Tax (Appeals). No change
4 Income Tax Department 03-Jun-2021 On appeal by the Company (Fortis Hospotel Limited) for Assessment Year 2017-18, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order proposing adjustment. Later on, Assessing Officer (AO) has passed assessment order confirming the adjustment proposed in TP Order, being interest amount paid on Compulsorily Convertible Debentures (CCDs) issued by the company. Amount under litigation is Rs. 56,11,28,717 and the matter is currently pending before Commissioner of Income Tax (Appeals). No change
5 Income Tax Department 24-Nov-2021 On appeal by the Company (Fortis Hospotel Limited) for Assessment Year 2018-19, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order on 30.07.2021 proposing adjustment amounting to INR 74.63 Cr which is interest expense claimed on Compulsorily Convertible Debentures (CCDs) issued by the company to FGHIPL and consultancy expenses on the same. Later on, Assessing Officer (AO) has passed assessment order dt. 24.11.2021 confirming the adjustment proposed in TP Order. Amount under litigation is Rs. 33,26,19,748 and the matter is currently pending before Commissioner of Income Tax (Appeals). No change
6 Income Tax Department 28-Mar-2005 In case of Escorts Heart Institute and Research Centre Limited, On appeal by the Department for Assessment Year 2001-02, Assessment was done u/s 143(1)(a) on 29.08.2002. The Assessing Officer reopened the assessment and passed the assessment order dated 28.03.2005 making an addition of Rs.149.09 crores. The Assessing Officer held that registration of a society as a company under Part IX of the Companies Act tantamount to a transfer of assets and hence alleged addition on account of capital gain has been made. Company’s appeal allowed by Income tax appellate tribunal, revenue has filed appeal before Delhi High Court. Amount under litigation is Rs. 1,05,32,00,000 and the matter is currently pending before Delhi High Court. No change
7 Income Tax Department 15-Feb-2017 In case of International Hospital Limited for Assessment Year 2013-14, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order on 31.10.2016 proposing adjustment amounting to INR 569 million which is interest expense claimed on Compulsorily Convertible Debentures (CCDs) issued by the company to FGHIPL. Later on, Assessing Officer (AO) has passed assessment order dt. 15.02.2017 confirming the adjustment proposed in TP Order and also making disallowance u/s 14A read with rule 8D amounting to INR 60 million and u/s 36(i)(va) amounting to INR 0.26 million. An appeal filed before the Commissioner of Income-tax (Appeals), New Delhi on 30.03.2017 has been decided. Further appeal filed before ITAT on 18.04.2019. Departmental also in appeal. Demand raised at Rs.15,01,91,860/- vide order passed u/s 143(3), the same was revised at Rs.34,18,72,340/- vide order dated 17.05.2018 passed u/s 154. Amount under litigation is Rs. 34,18,72,340/- and the matter is currently pending before Income Tax Appellate Tribunal No change
8 Income Tax Department 10-May-2021 In case of International Hospital Limited for Assessment Year 2017-18, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order dated 11.01.2021 proposing adjustment of Rs.92,83,08,762/-. Later on, Assessing Officer (AO) has passed assessment order u/s 143(3) dated 10.05.2021 confirming the adjustment proposed in TP Order and making further disallowance u/s 36(1)(iii) at Rs.71,00,77,700/- and u/s 36(1)(va) at Rs.9,05,271/- thereby raising a demand of Rs.39.89Cr. Amount under litigation is Rs. 39,89,16,838/- and the matter is currently pending before Commissioner of Income Tax (Appeals). No change
9 Income Tax Department 25-Nov-2021 In case of International Hospital Limited for Assessment Year 2018-19, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order dated 30.07.2021 proposing adjustment of Rs.228,08,64,295/-. Later on, Assessing Officer (AO) has passed assessment order u/s 143(3) dated 25.11.2021 confirming the adjustment proposed in TP Order and making disallowance u/s 36(1)(iii) at Rs.75,05,77,475/- and u/s 36(1)(va) at Rs.12,00,000/- thereby raising a demand of Rs.187.35Cr. Amount under litigation is Rs. 1,87,35,22,640 and the matter is currently pending before Commissioner of Income Tax (Appeals). No change
10 Income Tax Department 21-Mar-2024 Fortis Hospitals Limited, a material subsidiary of the Company has received an Income tax assessment order for Assessment Year 2022-23 (Financial Year 2021-22), wherein a demand of Rs.89.53 Crores (including interest of Rs.9.54 Crores) has been raised. The matter is currently pending before Commissioner of Income Tax (Appeals). No change
11 Office of the Principal Commissioner” GST, Gurugram, 18-Jul-2024 GST Department of Haryana has issued Show Cause Notice alleging that the company i.e. Fortis Hospitals Limited is charging MRP from IPD patient for medicine, consumable and implant which include GST and not remitting the same to government exchequer. Thus, the subsidiary Company i.e . Fortis Hospitals Limited has filed the writ petition by challenging the show cause notice issued by the- Office of the Principal Commissioner GST, Gurugram. Amount under Litigation is Rs.61.19 Crore plus interest and penalty and the matter is currently pending before Punjab and Haryana High Court. No change
12 Income Tax Department 03-Apr-2025 In case of International Hospital Limited, Income Tax Demand order amounting to Rs.76,19,13,970/- has been raised to IHL vide Order under Section 147/143(3)/144C read with Section 144B of the Income Tax Act, 1961 in respect of Assessment year 2019-20 (Financial year 2018-19). An Appeal before Commissioner of Income Tax (Appeals) has been filed on 30.04.2025 and the same is currently pending. No change
13 The Office of Commissioner, CGST, Audit-I, CR Building, IP Estate, New Delhi 29-Sep-2025 GST Department of Delhi has issued Show Cause Notice alleging that the company i.e. Escorts Heart Institute and Research Centre Limited is charging MRP from IPD patient for medicine or drugs and consumable which include GST and not remitting the same to government exchequer. Thus, the subsidiary Company i.e . Escorts Heart Institute and Research Centre Limited has filed the writ petition by challenging the show cause notice issued by the- Office of the Commissioner CGST, Audit-I, Delhi. Amount under Litigation is Rs.6.66 Crore plus interest and penalty and the matter is currently pending before Delhi High Court. Delhi High Court (HC) has issued Hearing Order dated 19.12.2025 wherein HC has directed to the Company to file reply to SCN before GST department of Delhi . Reply filed with GST Authority and order passed confirming the demand subject to final adjudication by Delhi HC.
14 State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101 29-Dec-2025 In case of Fortis Health Management Limited, GST Department of Tamil Nadu has issued GST Order for FY 2020-21, wherein GST department has denied the exemption on supply of healthcare services. The Company is in process of filing appeal before GST Fist Appellat Authority. Amount under litigation is Rs.1.68 Crore along with Interest of Rs.1.42 Crore & penalty of Rs.1.68 Crore has been raised. Appeal filed on 10th March 26
15 State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101 29-Dec-2025 In case of Fortis Health Management Limited, GST Department of Tamil Nadu has issued GST Order for FY 2021-22, wherein GST department has denied the exemption on supply of healthcare services. The Company is in process of filing appeal before GST Fist Appellat Authority. Amount under litigation is Rs.3.19 Crore along with Interest of Rs.2.17 Crore & penalty of Rs.3.19 Crore has been raised. Appeal filed on 10th March 26
16 State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101 29-Dec-2025 In case of Fortis Health Management Limited, GST Department of Tamil Nadu has issued GST Order for FY 2022-23, wherein GST department has denied the exemption on supply of healthcare services. The Company is in process of filing appeal before GST Fist Appellat Authority. Amount under litigation is Rs.3.26 Crore along with Interest of Rs.1.59 Crore & penalty of Rs.3.26 Crore has been raised. Appeal filed on 09th March 26
17 Income Tax Department 27-Mar-2026 Income Tax Authority has issued assessment order dated 27.03.2026 for AY 2024-25 wherein demand of INR 117.04 Crores has been raised. The Company is evaluating all options including filing an appeal and rectification application against the said order. Appeal to be filed
18 State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101 02-Jan-2026 GST Authority had issued show cause notice for an amount of INR 570.00 lakhs (including penalty of INR 285.00 lakhs) for the FY 2023-24. On submission of response by the Company, GST Authority has passed order and confirmed demand of INR 597.93 lakhs (including interest & penalty of INR 79.29 lakhs & INR 259.32 lakhs respectively). The show cause notice in relation to balance amount has been dropped. Appeal to be filed
19 Income Tax Department 27-Mar-2026 Income Tax Authority has issued assessment order dated 27.03.2026 for A.Y. 2021-22 wherein demand of INR 149.12 Crores has been raised. The Company is evaluating all options including filing an appeal and rectification application against the said order. Appeal to be filed
20 DCIT 30-Nov-2018 Disposed off in favour of assessee by Order of CIT (A), dated 27.05.2024. However DCIT, Income Tax – Gurugram filed an appeal before ITAT. Now the matter is pending with ITAT. Disposed off in favour of assessee by Order of ITAT, dated 22/07/2025.
21 DCIT 19-Jan-2018 Pending before CIT(A) / NFAC Pending before CIT(A) / NFAC
22 DCIT 18-Jan-2019 Pending before CIT(A) / NFAC Pending before CIT(A) / NFAC
23 DCIT 30-Jun-2020 Pending before CIT(A) / NFAC Pending before CIT(A) / NFAC